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Myasthenia gravis (MG)' is an autoimmune disease of skeletal muscle that is
characterized by prominent thymic pathology (reviewed in 1). Lymphoid follicles
in the medulla are increased in number, often with germinal centers, and B
lymphocytes (2) and DR' cells are numerous (3). The thymus in MG is a site for
the production ofantibodies to nicotinic acetylcholine receptors (AChR) (4), the
serologic hallmark of acquired MG and the cause of impaired neuromuscular
transmission. Thymoma, a slowly growing epithelial tumor that rarely metasta-
sizes, occurs in ^-15% ofpatients with MG, and more impressively, it has been
estimated that 35% of patients with thymoma either have MG or will develop
MG (5). The basis of this striking association between thymoma and MG is not
known.
In 1960, Strauss et al. (6) reported that sera of patients with MG contained
antibodies that reacted with cross-striations of skeletal muscle. Although these
striational autoantibodies (StrAb) were the first organ-specifc autoantibodies
found in MG, the pathogenic significance of StrAb, if any, is unknown. They
are very infrequent in patients <20 yr old but are found in 55% of MG patients
:60 yr old (7). StrAb are frequently found with thymoma, occurring in 80-90%
ofpatients with MG and thymoma, and in 24% ofpatients with thymoma in the
absenceofclinical signs of MG (8-10). They are rarely found in other conditions.
In MG, autoantibodies to AChR are found in higher titer in association with
StrAb than in their absence (7).
The stimulus for production of StrAb is unknown. Their association with
thymoma and the findings that these antibodies bind to thymic epithelial cells (8,
11) and thymic myoid cells (12, 13), in addition to skeletal muscle, suggest that
the thymus has a central role in the induction of StrAb. Identification of the
antigens to which StrAb bind in muscle and thymus should provide insight into
the nature of the thymus' association with these antibodies.
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TABLE I
Clinical Information aboutPatientsfrom Whom B Cell Lines Were Established
Materials and Methods
* All were generalized: 3, mild; 4, moderately severe with mild bulbar signs; 6, chronic severe,
respirator-dependent (18).
t Assayed by indirect immunofluorescence using rat skeletal muscle as substrate (7).
§ Assayed by immunoprecipitation of solubilized human muscle AChR complexed with ' 21I-a-
bungarotoxin (7); normal, 50.03 nM .
Biochemical identification of the antigens to which StrAb bind has been
hindered by the heterogeneity of muscle-reactive antibodies in sera of MG
patients (14) and by the diversity of proteins that constitute the contractile
apparatus of muscle. In immunofluorescence analyses, antibodies from different
patients have heterogeneous specificities at the level of the skeletal muscle
sarcomere. Some patients' serum antibodies bind to the I band, A band, or Z
line, whereas other patients' antibodies bind to several areas of the sarcomere
(14-16).
This paper describes the secretion of StrAb by lymphocytes cultured from
thymuses of MG patients, and the establishment of B cell clones secreting
monoclonal StrAb. B cells from thymus, thymoma, and peripheral blood were
transformed fortuitously by EBV during attempts to hybridize lymphocytes from
MG patients with the human myeloma, GK5. The monoclonal StrAb recognized
myosin, a actinin and actin in both thymus and muscle . Based on these and other
findings, we have developed a hypothesis concerning the stimulus for production
of StrAb in association with MG and thymoma.
Patients.
￿
The diagnosis of MG in all patients participating in this study was supported
by electromyographic examination and by the presence of AChR antibodies in serum
(17). The 72 patients from whom thymic lymphocytes were cultured had a median age of
34 yr (range, 19 mo to 74 yr); 54 were female and 18 were male; 18 had thymoma. All
had generalized muscle weakness and 23 were being treated with prednisone at the
time of surgery. A clinical synopsis of each patient from whom B cell clones were
established is shown in Table 1.
Thymic Cell Cultures.
￿
Th~mus tissues obtained at therapeutic thymectomy were disso-
ciated mechanically, and 10 cells/ml were cultured for 3-14 d at 37°C in a humidified
atmosphere of 5% C02 and 95% air in medium (RPMI 1640) containing 10% FCS, PWM
at 1/120 dilution (Grand Island Biological Co., Grand Island, NY), L-glutamine (0.06
mg/ml), 2-ME (10-4 M), streptomycin sulfate (0.2 mg/ml), and penicillin G (20 U/ml).













I M 56 Thymoma 30 3 60 7.4
11 M 22 Hyperplasia 2 3 120 11
III M 62 Normal 16 4 Negative 80
1V F 25 Hyperplasia 36 3 Negative 38
V F 23 Hyperplasia 16 4 Negative 19
VI F 70 Unknown 16 6 3,840 361
VII F 33 Normal 18 3 Negative 2.6WILLIAMS AND LENNON
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Serum supplementswere heated at 56'C for 30 min. Supernatants were assayed for StrAb
by an ELISA using human skeletal muscle protein antigens extracted in 0.6 M KCI, as
described below.
Establishment of Lymphocyte Clones.
￿
Thymus tissues of patients II-V were dissociated
mechanically and peripheral blood lymphocytes of patients V-VII were isolated by
centrifugation on Isopaque Ficoll of density 1.077 (19). Cells were cultured for 3 d as
described above, with addition of human AB serum (5%), except for the thymoma cells
(patient I), which were used immediately afterdissociation with collagenase (0.8%), trypsin
(0.25%), and DNase (0 .02 mg/ml) in PBS. All cells were washed in medium and mixed
2:1 with the human myeloma cell line, GK5, in 43% PEG 1500 (M.A. Bioproducts,
Walkersville, MD) for 2 min at 37 °C. After slow dilution with medium, the cells were
pelleted by centrifugation at 400 g at 22 °C, and were resuspended at 106 cells/ml in
RPMI 1640 containin¢ FCS (15%), aminopterin (10-6 M), thymidine (2 x 10-5 M),
deoxycytidine (2 x 10 . M), hypoxanthine (10-4 M), and antibiotics, and they were then
cultured for 1 mo in 96-well flat-bottomed plates. Wells with proliferating cells were
screened for StrAbby ELISA. Positive colonies were cloned at leastfour times by limiting
dilution and were grown in RPMI 1640 FCS (15%).
In an attemptto produce mAbs in ascites fluid, 5 x 10' cells ofeach antibody-producing
line were injected intraperitoneally into groups of six male athymic nude mice (three
BALB/C and three C57/BALB/C) 3 d after intraperitoneal injection of 0.5 ml sterile
Pristane (Aldrich Chemical Co., Milwaukee, WI).
Antigens.
￿
Purified myosin,actin, and a actininfrom bovine andchicken skeletal muscle
and chicken gizzard were purchased from Sigma Chemical Co. (St. Louis, MO). Cytoskel-
etal proteins were extracted from prefusion fetal human myoblasts (i. e., cultured for 5
d) in 1% Triton X-100 (20), and cytoskeletal proteins of adult human erythrocytes were
prepared by the method of Bennettand Stenbuck (21). Thymus and skeletal muscle were
obtained from a young female Lewis rat, weighing ^-200 g, which had been anesthetized
with Pentobarbitol and subjected to whole-body perfusion with PBS. Proteins were
extracted from rat tissues or frozen human limb muscle (amputated because of osteosar-
coma) by homogenizing for 30 s (setting 6, Polytron homogenizer; Brinkman Instruments
Co., Westbury, NY) in NaHCO3 (1 M, pH 7.5). After 30 min at 22 °C, the homogenate
was centrifuged (2,800 g, 10 min) and the resulting pellet was resuspended in KCI (0.6
M), NaH2PO4 (0.01 M), and Na2HP04 (0.01 M) and was incubated for 30 min at 22 °C.
The supernatant ofa second centrifugation (7,800 g, 15 min) wasdialyzed for 24 hagainst
NaH2P04 (0.01 M) and Na2HP04 (0.01 M) (pH 7.5 at 4°C). Protease inhibitors included
in all steps were: Pepstatin A (1 Ag/ml), PMSF (0.01 mM) (Sigma Chemical Co.), Aprotinin
(I KIU/ml) (Boehringer Mannheim Biochemicals, Inc., Indianapolis, IN), EGTA (1 mM),
and EDTA (1 mM).
Immunofuorescence Assays.
￿
Clonal cells were tested for Epstein-Barr nuclear antigen
(EBNA) by a complement-fixation assay (22). Monoclonal and serum antibodies were
tested for reactivity with nuclei, mitochondria, smooth muscle, and gastric mucosal cells
by using mouse stomach and kidney substrates (Quantafluor fluorescent autoantibody
test; Kallestad Laboratories, Inc., Austin, TX). Sections of rat, human and frog skeletal
muscle, frog thymus (4 ,m), or stretched myofibrils prepared from glycerinated rat muscle
(14) were used to assay StrAb in patients' sera (1:40) or in undiluted growth media from
cultures of the B cell clones by using fluoresceinated goat anti-human IgG, IgM, or IgA
(Southern Biotechnology Assoc., Inc., Birmingham, AL), diluted 1:100. In a dual fluores-
cence study of a mitochondrial-reactive IgM mAb, cultured human myoblast cells were
fixed with acetone and exposed first to the IgM mAb then to serum from a patient with
primary biliary cirrhosis (IgG antibodies) at 1:640 dilution. After washing, fluorescein-
labeled goat anti-human IgM and rhodamine-labeled anti-human IgG (Southern Bio-
technology Assoc., Inc.) were added together, each at a dilution of 1:100 . All samples
were examined with a Carl Zeiss, Inc. (Thornwood, NY) fluorescence microscope using
epi-illumination at 440 nm (fluorescein) or 510 nm (rhodamine).
Immunoblotting.
￿
Extracted muscle, thymus, and cytoskeletal proteins and standards of
known molecular weights (Bio-Rad Laboratories, Richmond, CA) were incubated for 301046 MONOCLONAL STRIATIONAL ANTIBODIES IN MYASTHENIA GRAVIS
TABLE II
Frequency of StrAb in Sera and in Growth Media of Cultured Thymic
Cellsfrom 72 Patients with MG
18 patients had thymoma and 6 of those were being treated with cortico-
steroids. StrAb were detected in sera of 14 of the 18 with thymoma, and
in the thymic growth media of 8 . Five ofthe 10 thymoma patients whose
growth media were negative for StrAb, and 2 of the 4 whose sera were
negative, were receiving corticosteroids. Media were assayed by ELISA
using human skeletal muscle protein antigens, and sera were assayed by
indirect immunofluorescence on sections of rat skeletal muscle.
min at 37°C in Tris-HCI (10 mM) SDS (2%), 2-ME (5%), and glycerol (10%), and applied
to slots in a polyacrylamide gel, 0.75 mm thick. After electrophoresis at 22°C (4 or 5%
stacking gel, 30 mA, 2 h; 5 or 10% separating gel, 80 mA, 2 h), proteins were transferred
electrically to nitrocellulose paper (0 .45,um). Duplicate strips were stained with Coomassie
Blue or processed for probing with antibodies (Hoefer Scientific Instruments, San Fran-
cisco, CA). After incubation for 16 h with undiluted growth media from cultures of B cell
clones, the strips were washed for 4 h in several changes of Tris-buffer Triton X-100
(0.5%). They were incubated for 6 hr with peroxidase-goat anti-human IgM (1 :250)
(Southern Biotechnology Assoc., Inc.), washed, and substrate was added.
ELISA.
￿
We coated the wells of an Immulon-I plate (Dynatech Laboratories, Inc.,
Alexandria, VA) with 0.015 mg of purified actin, a actinin, myosin, or BSA, or with 0.06
mg of proteins extracted from human skeletal muscle. Binding of StrAb was measured at
405 nm by a microplate reader (model MR600; Dynatech Laboratories, Inc.) after
sequential addition of alkaline phosphatase-anti-human Ig (Cappel Laboratories, Coch-
ranville, PA) and disodium p-nitrophenyl phosphate (Sigma Chemical Co.).
Results
Antibodies reactive with skeletal muscle were detected in supernatant media
ofthymic cells cultured from 59% of MG patients in whom StrAb were detectable
in serum and in 18% of patients without StrAb detectable in serum (Table I1) .
These values were significantly different (p <0.005) in X2 analysis.
Proliferating B cell lines were obtained from thymus, thymoma, or peripheral
blood of all patients whose lymphocytes we attempted to fuse with the GK5
myeloma (Table 111). However, antibodies reactive with skeletal muscle were
secreted only by cells from patients whose sera contained StrAb. Clones secreting
mAbs SA-IA and SA-1B were derived from patient 1. The clone secreting mAb
SA-2 was from patient 11 . These clones have secreted StrAb for over 12 mo in
continuous culture without any change in antigenic specificities (determined by
immunoblot analyses and immunofluorescence assays), and periodic recloning
has produced subclones only with the same antigenic specificity as the parental
clone. Use of isotype-specific anti-Ig in indirect immunofluorescence assays and
in immunoblots revealed that the three mAbs were of the IgM class.









Positive 13 9 22
Negative 9 41 50




Yield ofB Cell Lines Secreting StrAb
* Assayedby ELISAusingprotein antigens extractedfrom human muscle.
$B cell lines (and subsequently clones) secretingStrAb were obtained only
from patients with serum StrAb(p <0.001).
were EBNA+. The GK5 myeloma, also EBNA+, had a 7;8 balanced reciprocal
translocation; the formal karyotype was 46,XY,t(7;8)(p22;g22). Therefore, there
was no cytogenetic evidence that the antibody-secreting clones were hybridomas
derived from somatic fusion of GK5 and patients' B lymphocytes. Because
athymic nude mice injected with the clones did not develop ascites, unfraction-
ated growth media from cultured clones were used as sources ofmAbs.
mAb SA-I A discretely immunostained myofibrillar I bands (Fig. 1A). It did
not react with nuclei, smooth muscle, mitochondria, or gastric mucosal cells. In
agreement with its staining ofI bands, mAb SA-IA bound to actin in immuno-
blots (Fig. 2) and ELISAs (Fig. 3A). It recognized actins from human adult
muscle and erythrocytes, prefusion fetal myoblasts, and chicken gizzard (Figs. 2
and 3A). It also bound to a actinin from chicken gizzard and human muscle
sources (Figs. 2 and 3A). mAb SA-IA did not stain myofibril Z lines, despite the
demonstration ofa actinin in that location by a rabbit antiserum against a actinin
(Fig. 1 B).
mAb SA-1B also immunostained myofibrillar I bands (Fig. I C). It reacted only
with actin in ELISAs (Fig. 3B) and immunoblots (Fig. 4). mAb SA-1 B additionally
immunostained structures with the morphology and spatial distribution ofmito-
chondria in a variety of cell types (Fig. 5). In sections of skeletal muscle (Fig.
5B), the staining pattern was similar to that seen with sera from occasional
patients with MG and thymoma (Fig. 5D). With the exception of the striations,
staining with mAb SA-1B matched the pattern obtained with control antimito-
chondrial antibodies in serum of a patient with primary biliary cirrhosis (Fig.
5C) . In sections of other tissues mAb SA-I B bound only to mitochondria-rich
structures, e.g., proximal tubules in kidney. Other structures and tissues were
unstained, notably nuclei, smooth muscle, and gastric mucosal cells.
mAb SA-2 immunostained only myofibrillar A bands in muscle (Fig. 1 D), and
with the exception of thymus, it did not stain other structures or tissues, notably
nuclei, smooth muscle, mitochondria, or gastric mucosal cells. Consistent with
the A band localization in muscle, SA-2 reacted exclusively with myosin in
ELISAs (Fig. 3 C) and in immunoblot analyses (Fig. 6).







I Thymoma 288 124 8t
11 Thymus 22 21 2t
III Thymus 96 8 0
IV Thymus 65 29 0
V Thymus 144 17 0
Blood 192 42 0
V1 Blood 96 62 4$
VII Blood 336 141 01048 MONOCLONAL STRIATIONAL ANTIBODIES IN MYASTHENIA GRAVIS
FIGURE 1 .
￿
Rat myofibrils stained immunofluorescently by antibodies . Left, stretched ; right,
relaxed . Phase micrographs are at the bottom of each figure . (A) mAb SA-lA bound to I
bands but not to Z lines . (B) Polyclonal rabbit antiserum toaactinin bound to Z lines. (C) mAb
SA-I B bound to I bands. (D) mAb SA-2 bound to A bands . Patterns of staining were similar
with human and frog muscle . Bars represent 5Am .
All themAbs bound to proteins extracted from rat thymus that corresponded
in electrophoretic mobilities to their respective contractile protein antigens in
skeletal muscle (Figs . 6 and 7) . mAbSA-2 selectively stained medullary epithelialWILLIAMS AND LENNON
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FIGURE 2 . mAb SA-IA bound to actin (42,000) and a actinin (102,000) components of
contractile proteins that were electrophoresed and electroblotted to nitrocellulose paper .
Lanes A-E, Coomassie Blue staining ; lanesF-J,SA-1Aimmunostaining. LanesA and F, human
skeletal muscle proteins ; B and G, purified chicken gizzard actin; C and H, adult human
erythrocyte proteins ; D and I, human prefusion myoblast proteins ; E andJ, purified chicken
gizzard a actinin . Numbers indicate M, X 10-3 .
cells in sections of frog thymus (Fig . 8), but no specific staining was seen using
SA-1A or SA-1B .
Discussion
This study has shown that thymus and thymoma tissues of patients with MG
harbor B lymphocytes with the potential to secrete StrAb, which are a serologic
marker of both MG and thymoma. StrAb were secreted by freshly isolated
thymic cells cultured with PWM and by B cell clones derived from thymus,
thymoma, and peripheral blood .
We did not anticipate the fortuitous transformation of B lymphocytes by EBV
in attempts to fuse them with the human myeloma GK5. Presumably the
manipulations with PEG either enhanced the transfer of EBV from GK5 (which
is EBNA+) or activated endogenous EBV in the patients' lymphocytes . The latter
possibility is suggested by a report (23) that diploid EBV-transformed human
lymphocyte lines were generated in attempts to hybridize blood lymphocytes of
cancer patients to a myeloma line from mouse, a species that is not susceptible
to EBV infection .
The fact that lymphocytes committed to producing IgM are most susceptible
to EBV transformation (24) may explain why all the mAbs we obtained were
IgM, while StrAb in sera of patients with spontaneously acquired MG and
thymoma generally are of IgG class. It is noteworthy that StrAb of IgM class
appeared in sera of rheumatoid arthritis patients after treatment with D-penicil-
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ELISA titration of Bcell growth media containing (A)mAbSA-IA; (B)mAb SA-
IB; and (C) mAb SA-2. Wells were coated with actin (0-0), a actinin (t1---0), myosin
(0---0), or BSA (O---Q). Points indicate the mean of triplicate measurements, SE were
<10% of the mean .
Reactivity with cytoskeletal proteins has been reported (26, 27) as a frequent
specificity among human mAbs derived from subjects with a variety of clinical
disorders. However, several lines of evidence suggest that the antigenic specific-
ities of the monoclonal StrAb that we obtained were representative of the
autoantibodies in sera of patients with MG and thymoma. First, although prolif-
erating lymphocyte colonies were obtained from thymus or peripheral blood of
all MG patients studied, B cell lines secreting StrAb were obtained only from
patients who had StrAb in their sera . Second, the specificities of the mAbs for
myosin, a actinin, and actin were exhibited by serum antibodies in the two
patients from whom the B cell clones were established (28).
Consistent with early serological reports (29-31), the epitopes to which the
mAbs bound were conserved across species, and one mAb (SA-2) was reactive
with skeletal muscle myosin. mAb SA-2 bound to H chains of myosin from
muscle and thymus. It also immunofluorescently stained structures containing





mAb SA-1B bound to the actin (42,000) component of contractile proteins that
wereelectrophoresedand electroblotted to nitrocellulose . Lanes A-D, Coomassie Blue staining;
lanes E-H, SA-1B immunostaining. Lanes A and E, human skeletal muscle proteins ; B and F,
purified chicken gizzard actin; C and G, adult human erythrocyte proteins;D andH, human
prefusion myoblast proteins . Numbers indicate M, X 10- .
(28), indicating that it recognized an epitope found on cytoskeletal as well as
myofibrillar forms of myosin . Additionally, it immunostained thymic medullary
epithelial cells.
By usingseveral different assays to analyze themonoclonal StrAb, we identified
specificities ofStrAb that were previously unrecognized . In immunofluorescence
analyses on tissue sections or myofibrils, many epitopes may be inaccessible and
thus apparently nonreactive, because contractile proteins in myofilaments, stress
fibers, and related structures form multiprotein complexes . For example, neither
mAbs SA-IA nor SA-1B immunofluorescently stained smooth muscle in sections
of mouse stomach, but both reacted in immunoblots with y actin purified from
smooth muscle .
Another unanticipated finding was that mAb SA-IA bound to both a actinin
and actin . Antigenic relatedness between vertebrate actin and the actin-binding
protein a actinin has not, to our knowledge, been shown previously . However,
Maruta et al . (32) reported amino acid sequence homology and immunologic
crossreactivity between actin and actin-binding proteins of Physarum polyce-
phalum . Despite its reactivity with purified a actinin, SA-1A stained myofibril I
bands, which contain actin, and not myofibril Z lines, which contain a actinin . If
the SA-IA-reactive epitopes common to actin and a actinin are located at sites
where actin and a actinin bind to each other, as depicted in Fig . 9, this anomaly
would be explained, because antigenic sites in the myofibril Z line would be
inaccessible to SA-IA due to the known saturation ofa actinin with actin in that
location (33) .
Our observation that the actin-reactive mAb SA-1B bound to mitochondriaFIGURE 5.
￿
(A) Dual immunofluorescent staining of mitochondria in a human myoblast by
the IgM mAb SA-IB (upper, fluorescein) and polyclonal IgG antimitochondrial antibodies
(middle, rhodamine) ; corresponding phase contrast image (lower) . Mitochondria in rat skeletal
muscle immunofluorescently stained by mAb SA-IB (B), antimitochondrial antibodies from a
patient with primary biliary cirrhosis (C), or serum from a 42-yr-old male MG patient with
thymoma (D) . Mitochondria-containing midpiece (arrowheads) in a human spermatozoan






Contractile proteins from perfused rat skeletal muscle (lane 1) and thymus (lane
2), andH chains of purified bovine myosin (lane 3) were electrophoresed in a 5% separating
geland silver stained (A) or immunostained with mAb SA-2 after blotting to nitrocellulose (B) .
In each preparation, mAb SA-2 reacted only with myosin H chains (200,000). Numbers at
right, indicating Mr x 10-9 , were determined by staining coelectrophoresed proteins of known
molecularweights with silver (A) or Coomassie Blue (B) . Although proteins of M<<100 X 10 9
are not shown, data reported elsewhere (28) showed that mAb SA-2 did not react with any




Contractile proteins from perfused rat thymus (lane 1) or skeletal muscle (lane 2)
were electrophoresed in a 10% separating gel and silver stained (A) -or immunostained with
mAb SA-IA (B) or mAb SA-1B (C) after blotting to nitrocellulose . In both preparations, mAb
SA-1A reacted with a actinin (102,000)and actin (42,000) and mAbSA-IB reacted with actin
(42,000) . Numbers at right, indicating Mr X 10-9 , were determined by staining coelectrop-
horesed proteins of known molecular weights with silver (A) or Coomassie Blue (B and C) .
Distances between proteins in A do not correlate with those in B or C because of artefactual
distortion in drying the gel inA.1054 MONOCLONAL STRIATIONAL ANTIBODIES IN MYASTHENIA GRAVIS
FIGURE 8 .
￿
Immunofluorescent staining of medullary epithelial cells in frog thymus by (A)
mAb SA-2 and (B) antibodies in serum from a 48-yr-old male patient with MG and thymoma .
Cortical areas (arrows) were not stained . Bars represent 50 /Am .
suggests either that there is a similar epitope on mitochondria and all isoactins
or that actin is closely associated with mitochondria (34) . The latter proposal is
more likely because it has been reported that affinity-purified polyclonal anti-
bodies raised against7 actin react with mouse skeletal muscle mitochondria (35),
andthat human antimitochondrial antibodies bind to proteins with the molecular
















To explain the binding of mAb SA-IA to both actin and a actinin, we propose
that mAb SA-IA may bind to epitopes in both the actin-binding site on a actinin and the a
actinin-binding site on actin. Thus mAb SA-IA could bind to a actinin-binding sites on F
actin in the sarcomere I band, and it could bind to purified a actinin and G actin. However,
mAb SA-I A wouldnotbind to a actininin thesarcomere Z line becauseall binding sites on a
actinin in that region arefully complexedwith actin (33).
that is not associated with mitochondria, since it bound electroblotted actin from
adult human erythrocytes, which do not contain mitochondria.
In the context of MG, a most intriguing reactivity of the monoclonal StrAb
was their binding to muscle and nonmuscle isotypes of contractile proteins in
both thymus and muscle. It was first reported ^-25 yr ago (6) that StrAb
immunostain nonlymphoid cells in the thymic medulla, but the reactive antigens
have not previously been identified biochemically. Because AChR are expressed
on medullary epithelial cells of the human thymus (38), it is noteworthy that the
contractile proteins that are reactive with the monoclonal StrAb (myosin, a
actinin, and actin) copurify or colocalize (39-43) with AChR of mammalian
skeletal muscle. These cytoskeletal elements, presumed to integrate AChR in the
plasma membrane (44, 45), could conceivably be released by the focal membrane
lysis that follows activation of complement by anti-AChR antibodies (46-48).
However, it is unlikely that the mere release of these proteins provides a sufficient
immunogenic stimulus to induce StrAb because StrAb are rarely found (in the
absence of thymoma) in young patients with MG, regardless of the degree of
complement-mediated membrane damage .
The high prevalence of StrAb in patients with thymoma and in elderly MG
patients could be explained if the neoplastic transformation of thymic epithelial
cells to thymoma were a critical step in the induction of StrAb. Contractile
proteins are altered biochemically in the process of neoplastic transformation
(49). It is therefore conceivable that contractile proteins associated with AChR
in thymic epithelial cells might be altered antigenically as an early event in the
pretumorous evolution of thymoma. These proteins could be released extracel-
lularly through a complement-mediated immune attack against AChR on thymic
cells, or through incorporation of membrane proteins into the envelope of a
budding putative thymomagenic virus (1, 50). The expression of new epitopes
on contractile proteins associated with AChR and the release of those proteins
from thymic epithelial cells undergoing neoplastic transformation may provide
the immunogenic stimulus that elicits production of StrAb.
Summary
Striational autoantibodies (StrAb), which react with elements of skeletal muscle
cross-striations, occur frequently in patients with thymoma associated with myas-1056 MONOCLONAL STRIATIONAL ANTIBODIES IN MYASTHENIA GRAVIS
thenia gravis (MG). Dissociated thymic lymphocytes from 22 of 72 MG patients
secreted StrAb when cultured with PWM . A high yield of EBV-transformed B
cell lines was established from thymus, thymoma, and peripheral blood of seven
patients with MG, but clones secreting StrAb arose only from the three patients
who had StrAb in their sera. The monoclonal StrAb bound to A bands or I
bands in skeletal muscle of human, rat, and frog. One bound to mitochondria in
addition to myofibrillar I bands. None bound to nuclei, smooth muscle, or gastric
mucosal cells.
In immunoblot analyses and ELISAs the monoclonal StrAb bound to muscle
and nonmuscle isotypes of myosin, a actinin, and/or actin . All bound to contrac-
tile proteins common to thymus and muscle, and one selectively immunostained
epithelial cells of the thymic medulla. From these antigenic specificities we suggest
that StrAb might arise as an immune response directed against the cytoskeletal
anchoring proteins associated with nicotinic acetylcholine receptors in thymic
epithelial cells undergoing neoplastic transformation to thymoma.
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Note added in proof As an alternative explanation for the association of thymoma and StrAb, we
suggest that protein products ofa class of hybrid oncogenes exemplified by one-D and vfgr (truncated
cytoskeletal proteins joined to a putative transmembrane receptor and/or tyrosine kinase) may be
the immunogenic stimulus for StrAb. Thus, anti-StrAbs, and perhaps anti-AChR antibodies and MG
also, could arise as the result of an intrathymic antitumor immune response to a novel oncogene
product (51, 52).
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